Senseonics Holdings Inc (SENS) Downgraded by Zacks Investment Research to Hold
Senseonics Holdings Inc (NYSEMKT:SENS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday.
According to Zacks, “Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. “
Other analysts have also issued research reports about the stock. Canaccord Genuity reiterated a “buy” rating and issued a $6.00 target price on shares of Senseonics Holdings in a research report on Wednesday, August 10th. B. Riley initiated coverage on shares of Senseonics Holdings in a research report on Sunday, October 2nd. They set a “buy” rating and a $5.50 price target on the stock. Finally, Leerink Swann restated an “outperform” rating and set a $6.00 price target (up from $4.50) on shares of Senseonics Holdings in a research report on Thursday, September 22nd. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $5.25.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/12/senseonics-holdings-inc-sens-downgraded-by-zacks-investment-research-to-hold.html
Shares of Senseonics Holdings (NYSEMKT:SENS) opened at 3.27 on Wednesday. The company has a 50-day moving average of $3.88 and a 200-day moving average of $3.62. Senseonics Holdings has a 52-week low of $2.53 and a 52-week high of $4.24. The stock’s market capitalization is $305.38 million.
Senseonics Holdings (NYSEMKT:SENS) last announced its earnings results on Tuesday, August 9th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by $0.02. Equities research analysts anticipate that Senseonics Holdings will post ($0.49) EPS for the current year.
Institutional investors have recently modified their holdings of the company. Schwab Charles Investment Management Inc. purchased a new position in shares of Senseonics Holdings during the second quarter worth approximately $180,000. State Street Corp purchased a new position in shares of Senseonics Holdings during the second quarter worth approximately $1,185,000. Spark Investment Management LLC increased its position in shares of Senseonics Holdings by 72.5% in the second quarter. Spark Investment Management LLC now owns 67,800 shares of the company’s stock worth $266,000 after buying an additional 28,500 shares during the period. Abingworth LLP purchased a new position in shares of Senseonics Holdings during the second quarter worth approximately $2,026,000. Finally, Teachers Advisors Inc. purchased a new position in shares of Senseonics Holdings during the second quarter worth approximately $175,000.
Senseonics Holdings Company Profile
Senseonics Holdings, Inc, formerly ASN Technologies, Inc, is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.